Vanguard World Fund Files Proxy Materials

TL;DR

Vanguard World Fund filed proxy docs, no fee. Shareholders get info.

AI Summary

Vanguard World Fund filed a Definitive Additional Materials (DEFA14A) on November 4, 2025. The filing pertains to proxy statement information and indicates no fee was required for this filing. The document is related to the fund's diversification status.

Why It Matters

This filing provides shareholders with important information regarding the Vanguard World Fund's proxy voting and governance, which can impact investment decisions and fund management.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEFA14A) for a mutual fund, providing standard proxy information without indicating any unusual events or significant financial risks.

Key Players & Entities

• VANGUARD WORLD FUND (company) — Registrant
• 0000052848 (company) — Central Index Key
• 811-01027 (company) — SEC File Number
• 1934 Act (company) — SEC Act
• Vanguard Financials Index Fund (company) — Fund Name
• Vanguard Health Care Index Fund (company) — Fund Name

FAQ

Filing Documents

• f43280d1.htm (DEFA14A) — 15KB
• 0001193125-25-263970.txt ( ) — 17KB
• S000004449
• C000012220 (VFAIX)
• C000012221 (VFH)
• S000004450
• C000012222 (VHCIX)
• C000012223 (VHT)

From the Filing

NON DIVERSIFICATION DEF A14A DIVERSIFICATION NON DIVERSIFICATION DEF A14A Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) [ ] Definitive Proxy Statement [X] Definitive Additional Materials [ ] Soliciting Material under Rule 14a-12 Vanguard World Fund (Name of Registrant as Specified in its Declaration of Trust) Payment of Filing Fee (Check the appropriate box): [X] No fee required. [ ] Fee computed on table below per Exchange Act Rules 14a-6(i) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined): (4) Proposed maximum aggregate value of transaction: (5) Total Fee Paid: [ ] Fee paid previously with preliminary materials. [ ] Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11 (a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing. (1) Amount previously paid: (2) Form, schedule or registration statement no.: (3) Filing Party: (4) Date filed: #FirstName# , I’m writing to let you know that on November 4, 2025, Vanguard announced that it has secured shareholder approval via proxy vote to change the diversification status of both the ETF and mutual fund share classes of Vanguard Financials Index Fund (ETF Shares: VFH, CUSIP 92204A405; Admiral Shares: VFAIX, CUSIP 92204A835) from diversified to non-diversified. Vanguard is still aiming to secure shareholder approval to change the diversification status of Vanguard Health Care Index Fund (ETF Shares: VHT, CUSIP 92204A504; Admiral Shares: VHCIX, CUSIP 92204A827) by extending the proxy solicitation period. Please encourage your clients to vote now. Shareholders can vote their shares using one of the following methods: • Online , by visiting the website provided on their proxy card or email notification. • By phone , by calling the toll-free phone number on their proxy card or on the website provided in the proxy materials. • By mail , by signing and dating their proxy card. If you have additional questions, please don’t hesitate to contact us. #VGI_Name# #VGI_Title# Phone: #VGI_Phone#, Ext. #VGI_EXT# ------------------------------------------------------------------------------------------------------------------------------ For more information about Vanguard funds and ETFs, visit advisors.vanguard.com to obtain a prospectus or, if available, a summary prospectus. Investment objectives, risks, charges, expenses, and other important information are contained in the prospectus; read and consider it carefully before investing. Vanguard ETF Shares are not redeemable with the issuing fund other than in very large aggregations worth millions of dollars. Instead, investors must buy and sell Vanguard ETF Shares in the secondary market and hold those shares in a brokerage account. In doing so, the investor may incur brokerage commissions and may pay more than net asset value when buying and receive less than net asset value when selling. All investing is subject to risk, including the possible loss of the money you invest. CGS identifiers have been provided by CUSIP Global Services, managed on behalf of the American Bankers Association by Standard & Poor's Financial Services, LLC, and are not for use or dissemination in a manner that would serve as a substitute for any CUSIP service. The CUSIP Database, © 2025 American Bankers Association. "CUSIP" is a registered trademark of the American Bankers Association. FOR FINANCIAL ADVISOR USE ONLY. NOT FOR PUBLIC DISTRIBUTION. © 2025 The Vanguard Group, Inc. All rights reserved. Vanguard Marketing Corporation, Distributor.

View Full Filing

View this DEFA14A filing on SEC EDGAR